DUBLIN--(BUSINESS WIRE)--The "Global Stem Cell Therapeutics Market - Segmented by Product, by Therapeutic Applications, by Treatment Types, and Technology, By Type of Banking - Growth, Trends and Forecasts (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The Behavioral Rehabilitation Market is expected to witness a CAGR of 13.7% during the forecast period. North America dominates the global market due to high incidence diseases such as cancer and diabetes which can now be cured by stem cell therapies.
Currently, there is an increase in the number of clinical trials for testing future treatment possibilities of cord blood. Over 200 National Institutes of Health (NIH) funded clinical trials with cord blood are currently being conducted in the United States alone. The potential implications of the results are a cause of hope among scientists and healthcare providers.
In the United Kingdom, a petition has been submitted to increase the awareness of umbilical cord cells. In United States, CordBloodAwareness.org was created out of a need to increase awareness about the life-saving power of umbilical cord blood stem cells. Thus increasing awareness about umbilical stem cells.
Additionally, increase in the patient population, increase in the approval for clinical trials in stem cell research, growing demand as regenerative treatment option and rising R&D initiatives to develop therapeutic options for chronic disease are also fuelling Stem Cell Therapeutics Market globally.
One of the largest driving factors for the stem cell market in the US is the high purchasing power of the citizens in the country. There is an increasing incidence diseases such as cancer and diabetes which can now be cures by stem cell therapies. There is also increased awareness about the available stem cell procedures and therapies among people which in turn increases the demand for this market. Thus North America dominates Stem Cell therapeutics Market.
Key Developments in the Market
- February 2018: Astellas Acquires Universal Cells, Inc. to create cell therapy products.
- January 2018: Astellas Completes Acquisition of Mitobridge, Inc.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities And Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Company Profiles
- Vericel Corporation
- Astellas Pharma
- Fate Therapeutics Inc.
- Cytori Therapeutics Inc.
- Geron Corporation
- Thermo Fisher Scientific
- Pluristem Therapeutics Inc.
- Viacyte Inc.
- Osiris Therapeutics Inc.
- Capricor Therapeutics Inc.
10. Future Outlook of the Market
For more information about this report visit https://www.researchandmarkets.com/research/tmdwbp/global_stem_cell?w=4